Clinical trial
Fluorescence Visualization and Image Quality Evaluation of Digital Visualization of Suspected Grade III and/or IV Gliomas During Neurosurgery (Leica GLOW400)
NCT07366892 is registered in ClinicalTrials.gov with Leica Microsystems (Schweiz) AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fluorescence Visualization and Image Quality Evaluation of Digital Visualization of Suspected Grade III and/or IV Gliomas During Neurosurgery (Leica GLOW400)
- Lead sponsor
- Leica Microsystems (Schweiz) AG
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 1, 2026
- Completion date
- May 31, 2027
- Enrollment
- 37 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
glioblastoma (gbm), glioma, neurosurgical procedure, suspected grade iii and iv gliomas requiring surgical intervention